The Australian biotech Inventia Life Science has opened an office and facility in Wilmington, Delaware.
The new location is based at the Innovation Space, which offers lab space and resources to science startups.
Inventia Life Science had investigated a handful of other regions before settling on Delaware, including Philadelphia, San Diego and Texas.
The bioprinting company has also hired its first U.S. employee, Dwayne Dexter as director of sales and operations. Dexter has a Ph.D. in cellular and molecular biology.
Inventia Life Science recently won AU$35 million in Series B funding. The company has won approximately AU$45 million to date.
Inventia’s Rostrum [Image courtesy of Inventia Life Science]
Inventia focuses on creating life-like 3D human tissues for drug and therapy research. The company’s Rastrum 3D cell culture platform can be used for a variety of biomedical applica…